Elipovimab

Tax included
Elipovimab is a potent broadly neutralizing HIV-1 antibody for the targeted elimination of HIV-infected cells
HY-P99937

Data sheet

Size
Multiple sizes
Reactivity
HIV
Application
COVID-19-anti-virus
CAS
2101210-43-7